Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
526 JPY | +0.77% | +1.94% | +6.05% |
04-17 | NAOS Ex-50 Declares Quarterly Dividend | MT |
04-03 | ARS Pharmaceuticals Submits Response to FDA Letter for Neffy | DJ |
Sales 2022 | 54.92B 354M 483M | Sales 2023 | 57.07B 367M 501M | Capitalization | 21.45B 138M 189M |
---|---|---|---|---|---|
Net income 2022 | 1.71B 10.99M 15.01M | Net income 2023 | 2B 12.89M 17.59M | EV / Sales 2022 | 0.33 x |
Net cash position 2022 | 3.45B 22.23M 30.35M | Net cash position 2023 | 3.8B 24.44M 33.36M | EV / Sales 2023 | 0.31 x |
P/E ratio 2022 |
12.5
x | P/E ratio 2023 |
10.7
x | Employees | 1,591 |
Yield 2022 |
3.99% | Yield 2023 |
4.18% | Free-Float | 29.06% |
1 day | +0.77% | ||
1 week | +1.94% | ||
Current month | -2.59% | ||
1 month | -1.31% | ||
3 months | -0.85% | ||
6 months | +9.47% | ||
Current year | +6.05% |
Managers | Title | Age | Since |
---|---|---|---|
Yuji Ii
DFI | Director of Finance/CFO | - | - |
Kan Yoshimura
PSD | President | 62 | 84-03-31 |
Hiroaki Oshima
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hiroo Shimada
BRD | Director/Board Member | 81 | 15-05-31 |
Kan Yoshimura
PSD | President | 62 | 84-03-31 |
Kenichi Miyajima
BRD | Director/Board Member | 69 | 21-06-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 19 M€ | +3.83% | ||
0.00% | 18 M€ | +16.15% | - | |
0.00% | 144,586 M€ | +14.49% | ||
0.00% | 66,066 M€ | +14.68% | - | |
0.00% | 20,721 M€ | +13.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 526 | +0.77% | 33,000 |
24-04-25 | 522 | -0.57% | 16,800 |
24-04-24 | 525 | 0.00% | 16,400 |
24-04-23 | 525 | +0.57% | 16,700 |
24-04-22 | 522 | +1.16% | 26,800 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
+6.05% | 144M | |
-4.38% | 47.86B | |
+10.25% | 23.94B | |
+1.83% | 17.68B | |
+13.06% | 14.58B | |
+16.96% | 12.52B | |
+0.60% | 6.2B | |
+12.71% | 6.16B | |
+7.89% | 6.11B | |
+9.62% | 5.96B |
- Stock Market
- Equities
- 9788 Stock